Semaglutide and tirzepatide are both injectable weight-management medications, but they work through different receptor pathways, and which one is appropriate for a given person is a decision only a licensed provider can make.
Both belong to the broader family of GLP-1 medications central to modern weight-management care. They are similar enough to be confused and different enough that the distinction matters. Below is a plain comparison of what each one is, how they differ, and why the choice is never something a patient, a partner, or an affiliate decides alone.
What each medication is
Semaglutide is a GLP-1 receptor agonist. It mimics glucagon-like peptide-1, a hormone the body releases after eating that helps signal fullness and regulate appetite and blood sugar.
Tirzepatide is a dual GIP and GLP-1 receptor agonist. It acts on the same GLP-1 pathway as semaglutide and adds activity at a second receptor, GIP (glucose-dependent insulinotropic polypeptide), which is also involved in how the body handles blood sugar and appetite signals.
In short:
- Semaglutide: single-pathway (GLP-1).
- Tirzepatide: dual-pathway (GIP and GLP-1).
- Both are prescription medications used to support weight management under clinical supervision.
How they differ in practice
The headline difference is mechanism: one receptor target versus two. Beyond that, both are typically delivered as a subcutaneous injection on a regular schedule, and both are usually started at a lower dose that a provider adjusts over time based on how the individual responds and tolerates it.
The practical takeaways patients tend to care about:
- Delivery is similar. Both are injectables taken on a set cadence.
- Dosing is individualized. The starting dose, the pace of any changes, and the target dose are set by the prescribing provider, not chosen from a menu.
- Eligibility is not universal. Not everyone qualifies for either medication, and a provider reviews health history before anything is prescribed.
- Outcomes vary. Response differs from person to person, so no specific result can be promised.
For a deeper look at each option on its own, see our semaglutide telehealth guide and our tirzepatide telehealth guide.
Who actually decides
This is the part that matters most for anyone promoting a wellness platform. The comparison above is educational, not a recommendation and not a shortcut around the clinical process.
On the MedStands platform the clinical side is fully separate from the referral side. Licensed providers review each request, decide whether a medication is appropriate, and write any prescription. Licensed pharmacies handle fulfillment, refills, and shipping. The platform is LegitScript-certified. MedStands is not a medical practice and does not prescribe. Partners and affiliates never touch medication, inventory, or prescriptions, and they give no medical advice. Their role is to share a QR code or link, nothing more.
Common questions
Is tirzepatide just a stronger semaglutide?
No. They are different molecules with different receptor targets. Tirzepatide acts on two pathways (GIP and GLP-1) and semaglutide on one (GLP-1). "Stronger" is not the right frame; appropriateness for a specific person is a provider decision.
Can a patient pick which one they want?
They can express a preference, but the prescribing provider decides what, if anything, is appropriate after reviewing their health history. Not everyone qualifies for either medication.
Do partners or affiliates need to understand the pharmacology?
No. Partners and affiliates share a link or QR code and give no medical advice. All clinical questions are handled by the licensed provider and pharmacy.
Are both delivered the same way?
Both are commonly given as a subcutaneous injection on a regular schedule, with dosing individualized by the provider over time.
Share the platform, not the prescription
You do not need a clinical background to partner with MedStands. Businesses join the partner program and individuals join the affiliate program. Both are free: no setup fee, no monthly fee, nothing to buy. You share a QR code or personal link, referred customers are attributed to you with lifetime tracking, and you earn a fixed marketing fee for each active referred customer, set in advance and paid to your bank every month for as long as they stay active. Explore fits by industry to see where it lands for you.